By: Russell McLendon
Researchers have developed a novel compound that could transform the way we treat Alzheimer's disease, offering not just a new weapon but potentially a new strategy for battling the most common form of dementia worldwide.


Russell Mclendon is a Freelance Writer. He focuses on themes related to science, natural sciences, and healthcare, exploring topics such as aging and longevity, diet and nutrition, and wellness programs. His work has been featured in Films For Action, Yahoo News, ScienceAlert, and MSN.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston


Not enough data
This information evolves through artificial intelligence and human feedback. Improve this profile .